Hans Peter Hasler - Net Worth and Insider Trading

Hans Peter Hasler Net Worth

The estimated net worth of Hans Peter Hasler is at least $2 Million dollars as of 2024-05-06. Hans Peter Hasler is the SVP, International of Biogen Inc and owns about 9,158 shares of Biogen Inc (BIIB) stock worth over $2 Million. Hans Peter Hasler is also the Director of Minerva Neurosciences Inc and owns about 1,250 shares of Minerva Neurosciences Inc (NERV) stock worth over $2,963. Details can be seen in Hans Peter Hasler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hans Peter Hasler has not made any transactions after 2019-06-26 and currently still holds the listed stock(s).

Transaction Summary of Hans Peter Hasler

To

Hans Peter Hasler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hans Peter Hasler owns 4 companies in total, including Minerva Neurosciences Inc (NERV) , Patheon NV (PTHN) , and Biogen Inc (BIIB) among others .

Click here to see the complete history of Hans Peter Hasler’s form 4 insider trades.

Insider Ownership Summary of Hans Peter Hasler

Ticker Comapny Transaction Date Type of Owner
NERV Minerva Neurosciences Inc 2019-06-26 director
PTHN Patheon NV 2017-08-29 director
BIIB Biogen Inc 2008-11-01 Chief Operating Officer
2021-03-17 director

Hans Peter Hasler Latest Holdings Summary

Hans Peter Hasler currently owns a total of 2 stocks. Among these stocks, Hans Peter Hasler owns 9,158 shares of Biogen Inc (BIIB) as of October 13, 2006, with a value of $2 Million and a weighting of 99.85%. Hans Peter Hasler also owns 1,250 shares of Minerva Neurosciences Inc (NERV) as of June 26, 2019, with a value of $2,963 and a weighting of 0.15%.

Latest Holdings of Hans Peter Hasler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2006-10-13 9,158 217.51 1,991,957
NERV Minerva Neurosciences Inc 2019-06-26 1,250 2.37 2,963

Holding Weightings of Hans Peter Hasler


Hans Peter Hasler Form 4 Trading Tracker

According to the SEC Form 4 filings, Hans Peter Hasler has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 0 shares on October 13, 2006, which brought Hans Peter Hasler around $0.

According to the SEC Form 4 filings, Hans Peter Hasler has made a total of 1 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 1,250 shares on June 26, 2019, which cost Hans Peter Hasler around $56,000.

Insider Trading History of Hans Peter Hasler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hans Peter Hasler Trading Performance

GuruFocus tracks the stock performance after each of Hans Peter Hasler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hans Peter Hasler is 52.6%. GuruFocus also compares Hans Peter Hasler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hans Peter Hasler within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hans Peter Hasler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hans Peter Hasler

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.22
Relative Return to S&P 500(%) 16.37

Hans Peter Hasler Ownership Network

Ownership Network List of Hans Peter Hasler

No Data

Ownership Network Relation of Hans Peter Hasler


Hans Peter Hasler Owned Company Details

What does Minerva Neurosciences Inc do?

Who are the key executives at Minerva Neurosciences Inc?

Hans Peter Hasler is the director of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .

Minerva Neurosciences Inc (NERV) Insider Trades Summary

Over the past 18 months, Hans Peter Hasler made no insider transaction in Minerva Neurosciences Inc (NERV). Other recent insider transactions involving Minerva Neurosciences Inc (NERV) include a net sale of 27,394 shares made by Remy Luthringer , a net sale of 22,082 shares made by Geoff Race , and a net sale of 3,580 shares made by Frederick W Ahlholm .

In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,056 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,056 shares.

Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Minerva Neurosciences Inc Insider Transactions

No Available Data

Hans Peter Hasler Mailing Address

Above is the net worth, insider trading, and ownership report for Hans Peter Hasler. You might contact Hans Peter Hasler via mailing address: C/o Minerva Neurosciences, Inc., 1601 Trapelo Road, Suite 284, Waltham Ma 02451.

Discussions on Hans Peter Hasler

No discussions yet.